Mutation of herpesvirus saimiri ORF51 glycoprotein specifically targets infectivity to hepatocellular carcinoma cell lines

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Whitehouse, Adrian ^a   Turrell, Susan J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HERPESVIRUS VECTOR; ORF51 GLYCOPROTEIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; MEMBRANE PROTEIN; ORF51 PROTEIN, HERPESVIRUS SAIMIRI; SOMATOSTATIN RECEPTOR TYPE 1; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOMA CELL; CONTROLLED STUDY; GENE MUTATION; HERPES VIRUS SAIMIRI; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; ANIMAL; FLOW CYTOMETRY; GENE VECTOR; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; MUTATION; PATHOGENICITY; PHYSIOLOGY; SERODIAGNOSIS; TUMOR CELL LINE; VIROLOGY;

HERPESVIRIDAE; SAIMIRIINE HERPESVIRUS 2;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CLONING, MOLECULAR; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; GENETIC VECTORS; HEPARITIN SULFATE; HERPESVIRUS 2, SAIMIRIINE; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEUTRALIZATION TESTS; RECEPTORS, SOMATOSTATIN; VIRAL ENVELOPE PROTEINS;

EID: 79251562491     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/785158     Document Type: Article

References (51)

1. Roizman B., Carmichael L. E., Deinhardt F., Herpesviridae. Definition, provisional nomenclature, and taxonomy Intervirology 1981 16 4 201 217
2. Geevarghese S. K., Geller D. A., De Haan H. A., Hrer M., Knoll A. E., Mescheder A., Nemunaitis J., Reid T. R., Sze D. Y., Tanabe K. K., Tawfik H., Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver Human Gene Therapy 2010 21 9 1119 1128
3. Markert J. M., Medlock M. D., Rabkin S. D., Gillespie G. Y., Todo T., Hunter W. D., Palmer C. A., Feigenbaum F., Tornatore C., Tufaro F., Martuza R. L., Conditionally replicating herpes simplex virus mutant G207 for the treatment of malignant glioma: results of a phase I trial Gene Therapy 2000 7 10 867 874
4. Senzer N. N., Kaufman H. L., Amatruda T., Nemunaitis M., Reid T., Daniels G., Gonzalez R., Glaspy J., Whitman E., Harrington K., Goldsweig H., Marshall T., Love C., Coffin R., Nemunaitis J. J., Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma Journal of Clinical Oncology 2009 27 34 5763 5771
5. Macnab S., White R., Hiscox J., Whitehouse A., Production of an infectious Herpesvirus saimiri-based episomally maintained amplicon system Journal of Biotechnology 2008 134 3-4 287 296
6. Whitehouse A., Herpesvirus saimiri: a potential gene delivery vector (review) International Journal of Molecular Medicine 2003 11 2 139 148
7. Macnab S., Whitehouse A., Progress and prospects: human artificial chromosomes Gene Therapy 2009 16 10 1180 1188
8. Albrecht J.-C., Nicholas J., Biller D., Cameron K. R., Biesinger B., Newman C., Wittmann S., Craxton M. A., Coleman H., Fleckenstein B., Honess R. W., Primary structure of the herpesvirus saimiri genome Journal of Virology 1992 66 8 5047 5058
9. Falk L. A., Wolfe L. G., Deinhardt F., Isolation of Herpesvirus saimiri from blood of squirrel monkeys (Saimiri sciureus) Journal of the National Cancer Institute 1972 48 5 1499 1505
10. Fickenscher H., Fleckenstein B., Herpesvirus saimiri Philosophical Transactions of the Royal Society B: Biological Sciences 2001 356 1408 545 567
11. Smith P. G., Coletta P. L., Markham A. F., Whitehouse A., In vivo episomal maintenance of a herpesvirus saimiribased gene delivery vector Gene Therapy 2001 8 23 1762 1769
12. Simmer B., Alt M., Buckreus I., Berthold S., Fleckenstein B., Platzer Grassmann E. R., Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines Journal of General Virology 1991 72 8 1953 1958
13. Desrosiers R. C., Kamine J., Bakker A., Synthesis of bovine growth hormone in primates by using a herpesvirus vector Molecular and Cellular Biology 1985 5 10 2796 2803
14. Grassmann R., Fleckenstein B., Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line Journal of Virology 1989 63 4 1818 1821
15. Wieser C., Stumpf D., Grillhsl C., Lengenfelder D., Gay S., Fleckenstein B., Ensser A., Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors Gene Therapy 2005 12 5 395 406
16. Doody G. M., Leek J. P., Bali A. K., Ensser A., Markham A. F., de Wynter E. A., Marker gene transfer into human haemopoietic cells using a herpesvirus Saimiri-based vector Gene Therapy 2005 12 4 373 379
17. Shizuya H., Birren B., Kim U.-J., Mancino V., Slepak T., Tachiiri Y., Simon M., Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector Proceedings of the National Academy of Sciences of the United States of America 1992 89 18 8794 8797
18. Collins C. M., Medveczky M. M., Lund T., Medveczky P. G., The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome Journal of General Virology 2002 83 9 2269 2278
19. Calderwood M. A., Hall K. T., Matthews D. A., Whitehouse A., The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus Journal of General Virology 2004 85 1 147 153
20. Hall K. T., Giles M. S., Goodwin D. J., Calderwood M. A., Markham A. F., Whitehouse A., Characterization of the herpesvirus saimiri ORF73 gene product Journal of General Virology 2000 81 11 2653 2658
21. Calderwood M., White R. E., Griffiths R. A., Whitehouse A., Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence Journal of General Virology 2005 86 10 2703 2708
22. Griffiths R., Whitehouse A., Herpesvirus Saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2 Journal of Virology 2007 81 8 4021 4032
23. Griffiths R., Harrison S. M., Macnab S., Whitehouse A., Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence Journal of General Virology 2008 89 11 2843 2850
24. White R. E., Calderwood M. A., Whitehouse A., Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence Journal of General Virology 2003 84 12 3393 3403
25. Stevenson A. J., Clarke D., Meredith D. M., Kinsey S. E., Whitehouse A., Bonifer C., Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro Gene Therapy 2000 7 6 464 471
26. Griffiths R. A., Boyne J. R., Whitehouse A., Herpesvirus saimiri-based gene delivery vectors Current Gene Therapy 2006 6 1 1 15
27. Stevenson A. J., Cooper M., Griffiths J. C., Gibson P. C., Whitehouse A., Jones E. F., Markham A. F., Kinsey S. E., Meredith D. M., Assessment of Herpesvirus saimiri as a potential human gene therapy vector Journal of Medical Virology 1999 57 3 269 277
28. Smith P. G., Burchill S. A., Brooke D., Coletta P. L., Whitehouse A., Efficient infection and persistence of a herpesvirus saimiri-based gene delivery vector into human tumor xenografts and multicellular spheroid cultures Cancer Gene Therapy 2005 12 3 248 256
29. Means R. E., Characterization of the Herpesvirus saimiri Orf51 protein Virology 2004 326 1 67 78
30. Birkmann A., Mahr K., Ensser A., Yaubolu S., Titgemeyer F., Fleckenstein B., Neipel F., Cell surface heparan sulfate is a receptor for human herpesvirus and interacts with envelope glycoprotein K8.1 Journal of Virology 2001 75 23 11583 11593
31. Luna R. E., Zhou F., Baghian A., Chouljenko V., Forghani B., Gao S.-J., Kousoulas K. G., Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry Journal of Virology 2004 78 12 6389 6398
32. Smith P. G., Oakley F., Fernandez M., Mann D. A., Lemoine N. R., Whitehouse A., Herpesvirus saimiri-based vector biodistribution using noninvasive optical imaging Gene Therapy 2005 12 19 1465 1476
33. Bruix J., Boix L., Sala M., Llovet J. M., Focus on hepatocellular carcinoma Cancer Cell 2004 5 3 215 219
34. Lvy L., Renard C. A., Wei Y., Buendia M. A., Genetic alterations and oncogenic pathways in hepatocellular carcinoma Annals of the New York Academy of Sciences 2002 963 21 36
35. Bruix J., Hessheimer A. J., Forner A., Boix L., Vilana R., Llovet J. M., New aspects of diagnosis and therapy of hepatocellular carcinoma Oncogene 2006 25 27 3848 3856
36. Blker M., Schmitz M., Gocht A., Burghardt S., Schulz M., Brring D. C., Pace A., Greten H., De Weerth A., Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas Journal of Hepatology 2004 41 1 112 118
37. Reynaert H., Rombouts K., Vandermonde A., Urbain D., Kumar U., Bioulac-Sage P., Pinzani M., Rosenbaum J., Geerts A., Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma Gut 2004 53 8 1180 1189
38. Zou Y., Xiao X., Li Y., Zhou T., Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways Oncology Reports 2009 21 2 379 386
39. Lalioti M., Heath J., A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli Nucleic acids research 2001 29 3 E14
40. Wright R. M., Gram H., Vattay A., Byrne S., Lake P., Dottavio D., Binding epitope of somatostatin defined by phage-displayed peptide libraries Bio/Technology 1995 13 2 165 169
41. Patel Y. C., Somatostatin and its receptor family Frontiers in Neuroendocrinology 1999 20 3 157 198
42. Rossowski W. J., Coy D. H., Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs Biochemical and Biophysical Research Communications 1994 205 1 341 346
43. Li M., Wang X., Li W., Li F., Yang H., Wang H., Brunicardi F. C., Chen C., Yao Q., Fisher W. E., Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer Cancer Science 2008 99 11 2218 2223
44. O'Riordan C. R., Lachapelle A., Delgado C., Parkes V., Wadsworth S. C., Smith A. E., Francis G. E., PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo Human Gene Therapy 1999 10 8 1349 1358
45. Danielsson A., Elgue G., Nilsson B. M., Nilsson B., Lambris J. D., Ttterman T. H., Kochanek S., Kreppel F., Essand M., An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood Gene Therapy 2010 17 6 752 762
46. Roy E. J., Cho B. K., Rund L. A., Patrick T. A., Kranz D. M., Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate International Journal of Cancer 1998 76 5 761 766
47. Yoon S.-K., Mohr L., O'Riordan C. R., Lachapelle A., Armentano D., Wands J. R., Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate Biochemical and Biophysical Research Communications 2000 272 2 497 504
48. Douglas J. T., Curiel D. T., Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors Neuromuscular Disorders 1997 7 5 284 298
49. Conner J., Braidwood L., Brown S. M., A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein Gene Therapy 2008 15 24 1579 1592
50. Shaw P. L., Kirschner A. N., Jardetzky T. S., Longnecker R., Characteristics of Epstein-Barr virus envelope protein gp42 Virus Genes 2010 40 3 307 319
51. Fingeroth J. D., Weis J. J., Tedder T. F., Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2 Proceedings of the National Academy of Sciences of the United States of America 1984 81 14 I 4510 4514